Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults
MRKAd5 gag HIV 1 型疫苗在全球健康成年人 1 期研究中的安全性和免疫原性
期刊:Aids Research and Human Retroviruses
影响因子:1.1
doi:10.1089/AID.2010.0151
Nicholson, Ouzama; DiCandilo, Fay; Kublin, James; Sun, Xiao; Quirk, Erin; Miller, Michelle; Gray, Glenda; Pape, Jean; Robertson, Michael N; Mehrotra, Devan V; Self, Steven; Turner, Katherine; Sanchez, Jorge; Pitisuttithum, Punnee; Duerr, Ann; Dubey, Sheri; Kierstead, Lisa; Casimiro, Danilo; Hammer For The Merck V/Hiv Vaccine Trials Network Study Team, Scott M
